GlassScriptPhysician profile
Geraldine A St Germain
NPI 1144354473
$2,955.78
in general payments reported to CMS, 2019-2025
34 companies · $461 in 2025
The $461 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $237 · 2021: $408 · 2022: $713 · 2023: $445 · 2024: $469 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,373.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $607.20 | 2019-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Exeltis, USA INC. | $280.03 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $186.76 | 2022-2025 | |
| Pfizer INC. | $181.06 | 2019-2024 | |
| Hologic Sales and Service, LLC | $169.54 | 2020-2025 | Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $129.89 | 2021-2025 | |
| Organon LLC | $126.16 | 2021-2025 | Nexplanon, Jada System |
| Inari Medical, INC. | $105.81 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $101.70 | 2019-2024 | Prolia, Evenity |
| Mylan Pharmaceuticals INC. | $100.18 | 2020-2022 | |
| Intuitive Surgical, INC. | $98.15 | 2023 | |
| Sumitomo Pharma America, INC. | $83.92 | 2024-2025 | Myfembree, Gemtesa |
| Ethicon US, LLC | $83.25 | 2022 | |
| Merck Sharp & Dohme LLC | $76.10 | 2020-2022 | |
| Astellas Pharma US INC | $73.89 | 2023-2025 | Veozah, Myrbetriq |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $64.94 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Convatec INC. | $46.36 | 2019-2022 | |
| Therapeuticsmd, INC. | $44.33 | 2020-2022 | |
| Coopersurgical, INC. | $43.58 | 2019-2021 | |
| Davol INC. | $38.34 | 2022 | |
| Roche Diagnostics Corporation | $37.64 | 2019 | |
| Duchesnay USA Incorporated | $33.50 | 2019 | |
| Avion Pharmaceuticals | $31.22 | 2022-2023 | Balcoltra |
| Radius Health, INC. | $30.96 | 2020 | |
| Myovant Sciences INC. | $30.90 | 2021 | |
| Meditrina | $22.62 | 2025 | |
| Scynexis, INC. | $20.76 | 2022 | |
| Aspira Women'S Health INC | $19.21 | 2022 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Becton, Dickinson and Company | $17.98 | 2024 | Bd Onclarity |
| Evofem Biosciences, INC. | $14.24 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.76 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.64 | 2021 | |
| Minerva Surgical, INC | $12.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geraldine St Germain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.